These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14530047)

  • 1. Active, specific immunotherapy for lung cancer: hurdles and strategies using genetic modification.
    Korst RJ; Crystal RG
    Ann Thorac Surg; 2003 Oct; 76(4):1319-26. PubMed ID: 14530047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why has active immunotherapy not worked in lung cancer?
    Thomas A; Giaccone G
    Ann Oncol; 2015 Nov; 26(11):2213-20. PubMed ID: 26232492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?
    Strioga MM; Darinskas A; Pasukoniene V; Mlynska A; Ostapenko V; Schijns V
    Vaccine; 2014 Jul; 32(32):4015-24. PubMed ID: 24837511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for lung cancers.
    Ho MY; Tang SJ; Sun KH; Yang W
    J Biomed Biotechnol; 2011; 2011():250860. PubMed ID: 21318107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    Saito K; Nakayama E; Valmori D
    PLoS One; 2016; 11(3):e0150623. PubMed ID: 26937656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
    Raez LE; Santos ES; Mudad R; Podack ER
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of malignant diseases. Challenges and strategies.
    Ko EC; Wang X; Ferrone S
    Int Arch Allergy Immunol; 2003 Dec; 132(4):294-309. PubMed ID: 14707461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.
    Chee J; Robinson BW; Holt RA; Creaney J
    Chest; 2017 Apr; 151(4):891-897. PubMed ID: 27769776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A
    Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of gene transfer in cancer immunotherapy.
    Dranoff G
    Forum (Genova); 1998; 8(4):357-64. PubMed ID: 9863030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic cancer vaccines.
    Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
    Perez CA; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT; Kao CJ; Wolf M; DeGregorio MW
    Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for lung cancer: ongoing clinical trials.
    Declerck S; Vansteenkiste J
    Future Oncol; 2014 Jan; 10(1):91-105. PubMed ID: 24143916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
    Wang X; Luo W; Ferrone S
    Medicina (B Aires); 2000; 60 Suppl 2():48-50. PubMed ID: 11188931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor specific CD8+ T cells in patients with lung cancer and healthy individuals.
    Karanikas V; Germenis A
    J BUON; 2009 Sep; 14 Suppl 1():S153-7. PubMed ID: 19785058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific active lung cancer immunotherapy. Immune correlates of clinical responses and an update of immunotherapy trials evaluations.
    Hollinshead A; Takita H; Stewart T; Raman S
    Cancer; 1988 Oct; 62(8):1662-71. PubMed ID: 3048633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific active immunotherapy in lung cancer: the induction of long-lasting cellular responses to tumour-associated antigens.
    Stewart T; Hollinshead AC; Harris JE; Raman S
    Recent Results Cancer Res; 1982; 80():232-9. PubMed ID: 7036287
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
    De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.